Lu Li

Active targeted Janus nanoparticles enable anti-angiogenic drug combining chemotherapy agent to prevent postoperative hepatocellular carcinoma recurrence.

Guangjun Nie, Suping Li, Bozhao Li, 2022, Biomaterials.

Immune Checkpoint Inhibitors Plus an Anti-VEGF Antibody as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis and Cost-Effectiveness Analysis

Deshi Dong, Shilei Yang, Bin Wu, 2022, Frontiers in Pharmacology.

Shenqi Fuzheng Injection (SFI) Enhances IFN-α Inhibitory Effect on Hepatocellular Carcinoma Cells by Reducing VEGF Expression: Validation by Gene Silencing Technique

F. Xue, Jin-xiang Fu, Sheng Huang, 2019, BioMed research international.